Absolute Bioavailability and ADME study of Savolitinib in Healthy Male Subjects

Trial Identifier:	D5084C00010
Sponsor:	AstraZeneca
Collaborator:	Quotient Sciences Limited
NCTID::	NCT04675021
Start Date:	November 2020
Primary Completion Date:	January 2021
Study Completion Date:	January 2021
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Ruddington, United Kingdom, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.